Notice: amp_is_available was called incorrectly. `amp_is_available()` (or `amp_is_request()`, formerly `is_amp_endpoint()`) was called too early and so it will not work properly. WordPress is currently doing the `pre_get_posts` hook. Calling this function before the `wp` action means it will not have access to `WP_Query` and the queried object to determine if it is an AMP response, thus neither the `amp_skip_post()` filter nor the AMP enabled toggle will be considered. It appears the theme with slug `publisher` is responsible; please contact the author. Please see Debugging in WordPress for more information. (This message was added in version 2.0.0.) in /home/runcloud/webapps/techilive/wp-includes/functions.php on line 5313
New Antibody Cocktail Treatment Used for COVID Patient - TechiLive.in

New Antibody Cocktail Treatment Used for COVID Patient

0

It can also be administered to those suffering from an immuno-compromising condition or those with weakened immunity on account of immune suppressive treatment.

‘The ‘antibody cocktail therapy’ is for those above the age of 65, who are isolating at home, have a saturation oxygen of 93, require no oxygen support but are at risk of developing a severe form of the infection on account of their co-morbidities such as obesity, diabetes, liver disease, heart ailments, or chronic lung disease.’


Loading...

Dr Zafar Ahmed, Senior Consultant – Critical Care, Pulmonology and Chest and Sleep Medicine in Fortis Hospital, said like antibodies, which are proteins generated by the body to fight disease, monoclonal antibodies are “artificially created in the lab”.

In this cocktail, Casirivimab and Imdevimab are monoclonal antibodies that specifically block the spike protein of SARS-CoV-2, thereby preventing the coronavirus attachment and entry into human cells.

As much as 600 grams of each are mixed forming the cocktail. This is another very important step that has been taken by the medical community to effectively combat the pandemic and help people recover faster.

Loading...

Fortis on Saturday announced that two doses of Roche India’s antibody cocktail (Casirivimab and Imdevimab) distributed by Cipla Ltd is available for administration to patients with mild and moderate Covid-19 infection.

Launched on May 24 in India by Roche India, the antibody cocktail has received emergency use authorization from the Central Drugs Standards Control Organisation.

Source: IANS

Loading...

Stay connected with us on social media platform for instant update click here to join our  Twitter, & Facebook

We are now on Telegram. Click here to join our channel (@TechiUpdate) and stay updated with the latest Technology headlines.

For all the latest Health News Click Here 

Loading...

 For the latest news and updates, follow us on Google News

Read original article here

Denial of responsibility! TechiLive.in is an automatic aggregator around the global media. All the content are available free on Internet. We have just arranged it in one platform for educational purpose only. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials on our website, please contact us by email – admin@techilive.in. The content will be deleted within 24 hours.

Loading...
Leave a comment